No description available.

No description available.

Background Antineoplastic drugs constitute an important cornerstone in treating malignant cancer diseases. The nurses administering these drugs risk developing short- and long-term side effects from exposure if not properly protected by personal protective equipment. The National Institute for Occupational Safety & Health produces guidelines and recommendations for healthcare personnel handling antineoplastic drugs in order to minimise exposure. Aim The aim of this study was to observe and describe registered nurses’ compliance to National Institute for Occupational Safety & Health guidelines and recommendations concerning the use of personal protective equipment during drug administration at a public hospital in Guangzhou, China. Method Data was collected at three different departments using structured direct observations, totalling 211 administrations encompassing day and evening shifts. Results Total compliance to National Institute for Occupational Safety & Health guidelines and recommendations was 0 percent as a result of non-existent gown use. The overall compliance for the use of double gloves was 76,3 percent. The Department of Medical Oncology had the highest department-specific compliance rate for double gloves at 80,7 percent, whereas the evening shift at Chemotherapy Outpatient Department boasted the highest shift-specific compliance rate for the same item at 83,3 percent. Conclusion Interventions are needed concerning the use of personal protective equipment, in particular the use of gowns. Obtained hospital-specific guidelines did not include the procedure of drug administration, warranting the implementation of hospital-specific standard operating procedure guidelines encompassing this aspect.

Made available in DSpace on 2015-05-14T13:16:40Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 894417 bytes, checksum: 3728c6fa4ba78da3d3577c603e2f91cf (MD5) Previous issue date: 2009-04-29 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / The antineoplastic drugs used in systemic treatment of cancer by interfering with the mechanisms of survival, and cell migration proliferation. By systemic, these drugs can reach the central nervous system causing possible reactions in normal cells, including regions of the visual cortex, responsible for visual perception. The role of contrast sensitivity (FSC) has been used to characterize the process by which the visual system processes the information of the various frequencies of stimuli received by sensory stimuli perceived. So, this study aimed to investigate whether the agents of antineoplastic drugs can alter the sensory threshold in women that used for the systemic treatment of breast carcinoma, using the FSC as a tool. Respecting ethical aspects necessary to conduct the study, 20 volunteers participated in the tests, with normal or corrected visual acuity, ten users of antineoplastic drugs administered in six cycles of the FAC scheme - 5- fluorouracil, doxorubicin and cyclophosphamide (Experimental Group, EG) and ten volunteers without condition and without identifiable antineoplastics use of drugs (Control Group, CG). Measures of sensory threshold were performed at the Laboratory of Perception, Neuroscience and Behavior, using visual stimuli of spatial frequencies of 0.25, 1, 4 and 8 c/deg (cycle per degree of visual angle). The stimuli were generated in shades of gray and on a video monitor at 150 cm from the screen. It used to be an experimental design with repeated measures and put psychophysical forced-choice with two alternatives of choice. The procedure for measuring the sensitivity was the presentation of successive pairs of simple stimuli (test and neutral) and the volunteers were asked to choose among them always, that contained the frequency space. Three consecutive correct responses were necessary to reduce the amount of contrast in a indeed and an error to increase it (20%). Each frequency space was estimated twice for each participant, generating 240 values of thresholds for contrast. The data were grouped into tables and spreadsheets in Microsoft Office sociodemographic profile of the second sample, the iron values of contrast for maximum and minimum frequency space for the two groups.The analysis of variance for measures spread showed a significant difference between the threshold contrast of EG and the CG (F (1,238) = 23.97, p<0001), in the other words, there was variation in contrast sensitivity between the groups. At the highest spatial frequency (8 cpg) women in the control group were 1.6 more sensitive than the experimental group, analyzing how the post-hoc Tukey test (p<0001). You can guarantee, then, that the variation in contrast sensitivity among women of EG and CG can be caused, possibly by using the FAC scheme administered for the treatment of breast carcinoma. Therefore, the hypothesis that women mastectomized when subjected to treatment with drugs antineoplastics may have changed their visual perception is confirmed and accepted. / As drogas antineoplásicas são utilizadas no tratamento sistêmico do câncer por interferir nos mecanismos de sobrevivência, proliferação e migração celular. Por via sistêmica, estas drogas podem atingir o sistema nervoso central causando possíveis reações em células normais, inclusive nas regiões do córtex visual, responsáveis pela percepção visual. A Função de Sensibilidade ao Contraste (FSC) tem sido utilizada para caracterizar o processo pelo qual o sistema visual transforma as informações das várias freqüências do estímulo sensorial recebido em estímulo percebido. Assim, o presente estudo teve como objetivo investigar se os agentes das drogas antineoplásicas podem alterar o limiar sensório em mulheres que a utilizaram para o tratamento sistêmico do carcinoma mamário, utilizando a FSC como instrumento. Respeitando os aspectos éticos necessários para a realização da pesquisa, participaram dos testes 20 voluntárias, com acuidade visual normal ou corrigida, dez usuárias de drogas antineoplásicas administradas em seis ciclos do esquema FAC - 5-fluorouracil, doxorrubicina (adriamicina) e ciclofosfamida (Grupo Experimental, GE) e dez voluntárias sem patologia identificável e sem uso de drogas antineoplásicas (Grupo Controle, GC). As medidas de limiar sensório foram realizadas no Laboratório de Percepção, Neurociências e Comportamento, utilizando estímulos visuais de freqüências espaciais de 0,25; 1; 4 e 8 cpg (ciclo por grau de ângulo visual). Os estímulos eram gerados em tons de cinza e apresentados num monitor de vídeo a 150 cm de distância da tela. Usou-se um delineamento experimental com medidas repetidas e o método psicofísico da escolha forçada com duas alternativas de escolha. O procedimento para medir a sensibilidade consistiu na apresentação sucessiva simples de pares de estímulos (teste e neutro) e as voluntárias foram orientadas a escolher sempre dentre eles, aquele que continha a freqüência espacial. Eram necessários três acertos consecutivos para diminuir a quantidade de contraste em uma unidade e um erro para aumentá-la (20%). Cada freqüência espacial foi estimada duas vezes por cada participante, gerando 240 valores de limiares de contraste. Os dados coletados foram agrupados em tabelas e planilhas do Microsoft Office segundo perfil sociodemográfico da amostra, valores de limiar de contraste máximos e mínimos por freqüência espacial para os dois grupos. A análise de variância para medidas repetidas mostrou diferença significante entre o limiar de contraste do GE e do GC (F (1,238) = 22,73; p<0,001), ou seja, houve variação na sensibilidade ao contraste entre os grupos. Na freqüência espacial mais alta (8 cpg) as mulheres do grupo controle foram 1,6 mais sensíveis do que o grupo experimental, analisado com o teste post-hoc Tukey (p<0,001). Pode-se afirmar, então, que a variação na sensibilidade ao contraste entre as mulheres do GE e GC pode ser causada, possivelmente, pelo uso do esquema FAC administrado para o tratamento do carcinoma mamário. Portanto, a hipótese levantada de que as mulheres mastectomizadas quando submetidas a tratamento com drogas antineoplásicas podem ter sua percepção visual alterada está confirmada e aceita.